Verona Pharma Analyst Ratings
Verona Pharma Analyst Ratings
Verona Pharma Analyst Ratings
Verona Pharma Analyst Ratings
Strategic Financing Secures Verona Pharma's Future Beyond 2026, Ensuring Buy Rating
Verona Pharma Analyst Ratings
Piper Sandler Sticks to Their Buy Rating for Verona Pharma (VRNA)
Verona Pharma Analyst Ratings
Buy Rating Affirmed on Verona Pharma Ahead of Ensifentrine's Expected FDA Approval and Strong Financial Standing
Verona Pharma Analyst Ratings
Truist Financial Sticks to Their Buy Rating for Verona Pharma (VRNA)
Buy Rating Affirmed: Verona Pharma's Promising Future With Ensifentrine and Expanding R&D Pipeline
Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX), Verona Pharma (VRNA) and Molina Healthcare (MOH)
Analysts Are Bullish on Top Healthcare Stocks: Verona Pharma (VRNA), ACADIA Pharmaceuticals (ACAD)
Verona Pharma Analyst Ratings
Piper Sandler Reaffirms Their Buy Rating on Verona Pharma (VRNA)
BTIG Keeps Their Buy Rating on Verona Pharma (VRNA)
BTIG Keeps Their Buy Rating on Verona Pharma (VRNA)
BTIG Reaffirms Their Buy Rating on Verona Pharma (VRNA)
Buy Rating for Verona Pharma Amid Potential GSK Acquisition and Anticipated FDA Approval